During the past decade, Marseille University Hospital conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Marseille University Hospital" #1 sponsor was "Nantes University Hospital" with 10 trials, followed by "University Hospital, Angers" with 5 trials sponsored, "University Hospital, Toulouse" with 4 trials sponsored, "Rennes University Hospital" with 3 trials sponsored and "University Hospital, Brest" with 3 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marseille University Hospital" #1 collaborator was "Institut National de la Santé Et de la Recherche Médicale, France" with 3 trials as a collaborator, "Ecole des Hautes Etudes en Santé Publique" with 2 trials as a collaborator, "CHU de Reims" with 1 trials as a collaborator, "Centre National de la Recherche Scientifique, France" with 1 trials as a collaborator and "Cure Parkinson" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Marseille University Hospital" are "Multiple Sclerosis" (2 trials), "Parkinson Disease" (2 trials), "Acromegaly" (1 trials), "Asthma" (1 trials) and "Atheromatous Arteritis" (1 trials). Many other conditions were trialed in "Marseille University Hospital" in a lesser frequency.

Most popular intervention types in "Marseille University Hospital" are "Other" (12 trials), "Drug" (9 trials), "Device" (8 trials), "Procedure" (5 trials) and "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "Levodopa" (2 trials), "Placebo" (2 trials), "ALGOS algorithm of case management" (1 trials), "ALK analysis on CTCs detected by ISET" (1 trials) and "Assessment of intellectual development, capacities of attention, learning process and degree of hyperactivity of the children between 6 and 9 years." (1 trials). Other intervention names were less common.

The vast majority of trials in "Marseille University Hospital" are 41 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Marseille University Hospital". undefined are not yet recruiting, 8 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Marseille University Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Marseille University Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 18 trials that are defined as “Not Applicable".